 |
News Releases
2011
2010
2009
2007
2006
2005
2004
|
|
|
| |
November 24, 2008 |
Protox Announces Positive Phase 2 BPH Results |
|
| |
November 13, 2008 |
Protox Reports 2008 Third Quarter Results |
| |
November 5, 2008 |
Protox Announces Amendments To Certain Outstanding Warrants |
| |
October 8, 2008 |
Protox Announces Positive 12 Month Data From BPH Study |
| |
September 30, 2008 |
Protox Appoints Dr. Jack Geltosky to its Board of Directors |
| |
September 3, 2008 |
Protox Completes Enrollment Of Phase 2 BPH Trial |
| |
August 11, 2008 |
Protox Reports 2008 Second Quarter Results |
| |
June 17, 2008 |
Protox Granted Orphan Status In Europe For Brain Cancer Treatment |
| |
May 23, 2008 |
Protox Completes $4.8 Million Private Placement |
| |
May 20, 2008 |
Protox to Present BPH Data at AUA Conference |
| |
May 15, 2008 |
Protox Doses First Patient In Phase 2 BPH Clinical Trial |
| |
May 13, 2008 |
Protox Reports 2008 First Quarter Results |
| |
May 5, 2008 |
Protox Announces Private Placement |
| |
April 30, 2008 |
Protox Announces Collaboration with FDA |
| |
April 16, 2008 |
Protox Announces Positive Long-Term Data From BPH Study |
| |
April 15, 2008 |
Protox Reports 2007 Financial Results And Achievements |
| |
April 8, 2008 |
Protox Initiates Phase 2 BPH Study |
| |
February 13, 2008 |
Protox To Present Prostate Cancer Data At ASCO Conference |
| |
January 30, 2008 |
Protox To Graduate To Toronto Stock Exchange |
| |
January 15, 2008 |
Protox Initiates Phase 2 Prostate Cancer Study |
| |
January 7, 2008 |
Protox Appoints Vice President, Business Development & Strategy |
| |
January 3, 2008 |
Protox Announces Positive Final Results From BPH Study |
|
|
|
